Physician profile
Michael A Frost
NPI 1114004587
$3,423.25
in general payments reported to CMS, 2019-2025
36 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $701 · 2023: $1,338 · 2024: $507 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923 · Entertainment: $33.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.90 |
| Entertainment | $33.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $563.12 | 2021-2024 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $342.15 | 2021-2023 | |
| Lilly USA, LLC | $331.84 | 2021-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $244.25 | 2022-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $211.24 | 2021-2024 | |
| Amgen INC. | $155.06 | 2021-2023 | Evenity, Prolia, Otezla |
| Edwards Lifesciences Corporation | $151.80 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $116.85 | 2021-2024 | Freestyle Libre 3, Mitraclip, Proclaim |
| Gilead Sciences, INC. | $110.92 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $99.14 | 2023 | Rexulti |
| Biodelivery Sciences International, INC. | $96.97 | 2021 | |
| Lucid Diagnostics INC. | $91.70 | 2022-2023 | |
| Opko Pharmaceuticals, LLC | $79.85 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Nestle Healthcare Nutrition INC. | $68.20 | 2021-2023 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Frost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.